NASDAQ: AMGNAmgen Inc Stock Ownership - Who owns Amgen?
Insider buying vs selling
Have Amgen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Murdo Gordon | EVP Global Commercial Ops | 2024-03-18 | 6,461 | $268.87 | $1.74MSell |
| Robert A. Bradway | Chairman CEO and President | 2024-03-18 | 20,560 | $268.87 | $5.53MSell |
| David M. Reese | EVP Chief Technology Officer | 2024-03-18 | 6,202 | $268.87 | $1.67MSell |
| Jonathan P. Graham | EVP Gen. Counsel Secy. | 2024-03-18 | 5,879 | $268.87 | $1.58MSell |
| Rachna Khosla | SVP Business Development | 2024-03-18 | 438 | $268.87 | $117.77kSell |
| Derek Miller | SVP Human Resources | 2024-03-18 | 475 | $268.87 | $127.71kSell |
| Nancy A. Grygiel | SVP CCO | 2024-03-18 | 703 | $268.87 | $189.02kSell |
| Matthew C. Busch | VP Finance CAO | 2024-03-18 | 146 | $268.87 | $39.26kSell |
| Esteban Santos | EVP Operations | 2024-03-18 | 6,137 | $268.87 | $1.65MSell |
| Peter H. Griffith | EVP CFO | 2024-03-18 | 5,168 | $268.87 | $1.39MSell |
AMGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AMGN insiders and whales buy or sell their stock.
AMGN Shareholders
What type of owners hold Amgen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.15% | 49,042,553 | $12.89B | Institution |
| Blackrock Inc | 8.92% | 47,812,390 | $12.56B | Institution |
| State Street Corp | 5.50% | 29,463,970 | $7.74B | Institution |
| Primecap Management Co | 2.72% | 14,591,468 | $3.83B | Institution |
| Morgan Stanley | 2.69% | 14,434,062 | $3.79B | Institution |
| Geode Capital Management LLC | 2.30% | 12,339,956 | $3.24B | Institution |
| Charles Schwab Investment Management Inc | 1.94% | 10,393,110 | $2.73B | Institution |
| Wells Fargo Company | 1.40% | 7,488,777 | $1.97B | Institution |
| Capital Research Global Investors | 1.25% | 6,706,651 | $1.76B | Institution |
| Price T Rowe Associates Inc | 1.22% | 6,564,710 | $1.72B | Institution |
AMGN vs General Drug Manufacturer Stocks
Amgen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.